Skip to main
AKBA
AKBA logo

Akebia Therapeutics (AKBA) Market Capitalization Overview

Market Cap: $953.37M as of Jul 2, 2025

$953.37M
Past Month+$99.81M (11.69%)
As of Jul 2, 2025, Akebia Therapeutics (AKBA) has a market capitalization of $953.37M. Over the past 30 days, its market cap has increased by 9.85%, while in the last 12 months, it has increased by 129.98%.

Market capitalization represents the total value of Akebia Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Akebia Therapeutics (AKBA) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Akebia Therapeutics (AKBA) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Akebia Therapeutics (AKBA) Market Cap History

DateMarket CapChange
Jul 1, 2025$937.62M+9.85%
Jun 2, 2025$853.57M+36.71%
May 1, 2025$624.35M+25.13%
Apr 1, 2025$498.96M+27.05%
Mar 3, 2025$392.73M-15.09%
Feb 3, 2025$462.55M+11.58%
Jan 2, 2025$414.55M-10.80%

Akebia Therapeutics (AKBA) End of Year Market Cap History

DateMarket CapChange
2025$953.37M+129.98%
2024$414.55M+77.46%
2023$233.61M+120.08%
2022$106.15M-73.16%
2021$395.41M-2.30%
2020$404.71M

FAQs About Akebia Therapeutics (AKBA) Market Cap

As of Jul 2, 2025, the market capitalization of Akebia Therapeutics (AKBA) is $953.37M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Akebia Therapeutics’s market capitalization has increased by 11.69%, changing from $853.57M to $953.37M as of Jul 2, 2025.

In the last 3 months, Akebia Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Akebia Therapeutics’s market capitalization increased from $233.61M in January to $414.55M in December, reflecting a 77.46% change.

In the past five years, Akebia Therapeutics (AKBA) has had a compound annual growth rate (CAGR) of 0.48% in market capitalization. This means its market cap has grown at an average rate of 0.48% per year.

Akebia Therapeutics (AKBA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.